Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
India
· Delayed Price · Currency is INR 208.79
+1.50 (0.72%)
Jul 1, 2025, 3:29 PM IST
Nath Bio-Genes (India) Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 888.99 | 774.1 | 379.95 | 41.81 | 292.16 | Upgrade
|
Cash & Short-Term Investments | 888.99 | 774.1 | 379.95 | 41.81 | 292.16 | Upgrade
|
Cash Growth | 14.84% | 103.73% | 808.85% | -85.69% | 32.89% | Upgrade
|
Accounts Receivable | 889.02 | 943.09 | 973.14 | 855.48 | 1,094 | Upgrade
|
Other Receivables | 36.52 | 64.08 | 63.68 | 71.79 | 73.96 | Upgrade
|
Receivables | 925.53 | 1,007 | 1,037 | 927.27 | 1,168 | Upgrade
|
Inventory | 3,380 | 2,303 | 2,078 | 2,203 | 2,263 | Upgrade
|
Prepaid Expenses | - | 2.9 | 3.6 | 3.48 | 2.8 | Upgrade
|
Other Current Assets | 1,705 | 1,629 | 1,699 | 1,502 | 1,635 | Upgrade
|
Total Current Assets | 6,900 | 5,717 | 5,198 | 4,678 | 5,361 | Upgrade
|
Property, Plant & Equipment | 2,432 | 2,406 | 2,340 | 2,329 | 2,333 | Upgrade
|
Long-Term Investments | 57.82 | 60.46 | 50.48 | 50.48 | 50.48 | Upgrade
|
Other Intangible Assets | 71.82 | 88.12 | 104.17 | 120.26 | 136.19 | Upgrade
|
Other Long-Term Assets | 442.16 | 421.59 | 235.4 | 217.86 | 14.35 | Upgrade
|
Total Assets | 10,262 | 8,802 | 7,928 | 7,395 | 7,895 | Upgrade
|
Accounts Payable | 794.84 | 432.96 | 277.36 | 427.82 | 264.43 | Upgrade
|
Accrued Expenses | 8.47 | 104.31 | 97.99 | 117 | 110.45 | Upgrade
|
Short-Term Debt | 1,095 | 49.12 | 10.33 | 18.84 | 121.47 | Upgrade
|
Current Portion of Long-Term Debt | - | 1,006 | 1,038 | 904.1 | 879.79 | Upgrade
|
Current Income Taxes Payable | 3.9 | 9.47 | 2.81 | 8.87 | 25.31 | Upgrade
|
Current Unearned Revenue | - | 645.95 | 513.23 | 238.37 | 220.36 | Upgrade
|
Other Current Liabilities | 1,751 | 376.96 | 224.87 | 227.91 | 108.23 | Upgrade
|
Total Current Liabilities | 3,653 | 2,624 | 2,164 | 1,943 | 1,730 | Upgrade
|
Long-Term Debt | 129.76 | 48.65 | 4.03 | 6.65 | 6.53 | Upgrade
|
Other Long-Term Liabilities | 35.43 | 6.66 | 5.52 | 7.71 | 5.69 | Upgrade
|
Total Liabilities | 3,818 | 2,703 | 2,196 | 1,976 | 1,762 | Upgrade
|
Common Stock | 190.04 | 190.04 | 190.04 | 190.04 | 190.04 | Upgrade
|
Additional Paid-In Capital | - | 1,335 | 1,335 | 1,335 | 1,335 | Upgrade
|
Retained Earnings | - | 4,444 | 4,086 | 3,774 | 4,486 | Upgrade
|
Comprehensive Income & Other | 6,254 | 129.7 | 120.43 | 120.22 | 121.93 | Upgrade
|
Total Common Equity | 6,444 | 6,099 | 5,732 | 5,419 | 6,133 | Upgrade
|
Minority Interest | - | - | - | -0.05 | - | Upgrade
|
Shareholders' Equity | 6,444 | 6,099 | 5,732 | 5,419 | 6,133 | Upgrade
|
Total Liabilities & Equity | 10,262 | 8,802 | 7,928 | 7,395 | 7,895 | Upgrade
|
Total Debt | 1,225 | 1,103 | 1,052 | 929.59 | 1,008 | Upgrade
|
Net Cash (Debt) | -336.01 | -329.36 | -672.17 | -887.78 | -715.63 | Upgrade
|
Net Cash Per Share | -17.53 | -17.33 | -35.37 | -46.72 | -37.66 | Upgrade
|
Filing Date Shares Outstanding | 12.99 | 19 | 19 | 19 | 19 | Upgrade
|
Total Common Shares Outstanding | 12.99 | 19 | 19 | 19 | 19 | Upgrade
|
Working Capital | 3,247 | 3,092 | 3,034 | 2,735 | 3,631 | Upgrade
|
Book Value Per Share | 496.02 | 320.94 | 301.61 | 285.16 | 322.71 | Upgrade
|
Tangible Book Value | 6,372 | 6,011 | 5,628 | 5,299 | 5,997 | Upgrade
|
Tangible Book Value Per Share | 490.49 | 316.31 | 296.12 | 278.84 | 315.54 | Upgrade
|
Land | - | 2,221 | 2,221 | 2,221 | 2,221 | Upgrade
|
Buildings | - | 48.67 | 33.78 | 31.28 | 31.02 | Upgrade
|
Machinery | - | 311.9 | 280.98 | 260.2 | 260.47 | Upgrade
|
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.